Zurich, Zurich - October 21, 2026 - PRESSADVANTAGE - The field of aesthetic medicine in Switzerland continues to evolve ...

As major health systems open their own programs, longevity medicine is gaining credibility and becoming more accessible.

The average one-year price target for Disc Medicine (NASDAQGM:IRON) has been revised to $118.56 / share. This is an increase of 12.67% from the prior estimate of $105.23 dated September 29, 2026.

Being born into a famous family can open doors, but it does not decide which door a person ultimately walks through. For ...

Europe has world-class biotech research, but can it scale? Nordic Life Science Days explores the capital, expertise, and ...

On October 20, 2026, Disc Medicine, Inc. entered into an Underwriting Agreement with Jefferies LLC, Leerink Partners LLC, Morgan Stanley & Co. LLC and Cantor Fitzgerald & Co., as representatives of ...

W ith their ability to home in on precise targets while ignoring everything else, monoclonal antibodies are powerful ...

Blue Cross Blue Shield of MA and Tufts Medicine partner to automate prior authorization via Humata Health and launch the ...

Foundation Medicine, Inc., a global, patient-focused precision medicine company, today announced the appointment of Chadi Nabhan, M.D., MBA, as chief medical officer, effective November 16, 2026. In ...

Dr. Michael Smith is a newcomer when it comes to holding public office — something he made clear when he was first approached ...

Prioritize AI-driven diagnostics, drug discovery and workflow automation; use partnerships, domestic infrastructure and localized supply chains to curb costs and scale adoption.Dublin, Oct. 22, 2026 ...

To transform the health of the American population, healthy food should be something we can prescribe, writes Dr. Sadiya Khan ...